Literature DB >> 20202590

Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Rachel S Klein1, Pamela A Morganroth, Victoria P Werth.   

Abstract

This article provides an overview of cutaneous lupus erythematosus, including classification schemes, disease subtypes, and therapy. It also describes the Cutaneous Lupus Erythematosus Disease Area and Severity Index, a novel clinical outcome instrument that quantifies cutaneous activity and damage in cutaneous lupus erythematosus. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20202590      PMCID： PMC3035848          DOI： 10.1016/j.rdc.2009.12.001

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN： 0889-857X            Impact factor:   2.670


  76 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 2.  Measurement of disease activity and outcome in atopic dermatitis.

Authors:  A Y Finlay
Journal:  Br J Dermatol       Date:  1996-10       Impact factor: 9.302

Review 3.  The lexicon of cutaneous lupus erythematosus--a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus.

Authors:  R D Sontheimer
Journal:  Lupus       Date:  1997       Impact factor: 2.911

4.  ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus.

Authors:  A Parodi; A Rebora
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

5.  Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.

Authors:  F J López-Longo; I Monteagudo; C M González; R Grau; L Carreño
Journal:  Lupus       Date:  1997       Impact factor: 2.911

6.  A multirater validation study to assess the reliability of acne lesion counting.

Authors:  A W Lucky; B L Barber; C J Girman; J Williams; J Ratterman; J Waldstreicher
Journal:  J Am Acad Dermatol       Date:  1996-10       Impact factor: 11.527

7.  Precise ultrastructural localization of in vivo deposited IgG antibodies in fresh perilesional skin of patients with bullous pemphigoid.

Authors:  M Sato; H Shimizu; A Ishiko; T Masunaga; M Akiyama; T Hashimoto; Y Kitajima; T Nishikawa
Journal:  Br J Dermatol       Date:  1998-06       Impact factor: 9.302

8.  Bullous systemic lupus erythematosus: revised criteria for diagnosis.

Authors:  J A Yell; J Allen; F Wojnarowska; G Kirtschig; S M Burge
Journal:  Br J Dermatol       Date:  1995-06       Impact factor: 9.302

9.  Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients.

Authors:  T Watanabe; T Tsuchida
Journal:  Dermatology       Date:  1995       Impact factor: 5.366

10.  Lupus panniculitis: clinical perspectives from a case series.

Authors:  P B Martens; K G Moder; I Ahmed
Journal:  J Rheumatol       Date:  1999-01       Impact factor: 4.666
View more
  12 in total

1.  A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.

Authors:  R Vasquez; D Wang; Q P Tran; B Adams-Huet; M-M Chren; M I Costner; J B Cohen; V P Werth; B F Chong
Journal:  Br J Dermatol       Date:  2012-09-13       Impact factor: 9.302

2.  Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma.

Authors:  Jan Dutz; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2011-10       Impact factor: 8.551

3.  [Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].

Authors:  M Sticherling
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

4.  Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis.

Authors:  Yunyoung C Chang; Victoria P Werth
Journal:  Curr Dermatol Rep       Date:  2013-01-24

5.  Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation.

Authors:  Allison C Billi; Feiyang Ma; Olesya Plazyo; Mehrnaz Gharaee-Kermani; Rachael Wasikowski; Grace A Hile; Xianying Xing; Christine M Yee; Syed M Rizvi; Mitra P Maz; Celine C Berthier; Fei Wen; Lam C Tsoi; Matteo Pellegrini; Robert L Modlin; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  Sci Transl Med       Date:  2022-04-27       Impact factor: 19.319

6.  Demographic and clinical characteristics of cutaneous lupus erythematosus at a paediatric dermatology referral centre.

Authors:  B Z Dickey; K E Holland; B A Drolet; S S Galbraith; V B Lyon; D H Siegel; Y E Chiu
Journal:  Br J Dermatol       Date:  2013-08       Impact factor: 9.302

7.  Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus.

Authors:  Rita Quelhas da Costa; M Elena Aguirre-Alastuey; David A Isenberg; Amanda M Saracino
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

Review 8.  Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.

Authors:  Theophanis P Karageorgas; Dimitrios D Tseronis; Clio P Mavragani
Journal:  J Biomed Biotechnol       Date:  2011-11-16

Review 9.  Cutaneous lupus erythematosus: An update.

Authors:  Carina M Grönhagen; Filippa Nyberg
Journal:  Indian Dermatol Online J       Date:  2014-01

10.  Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomised, controlled pilot study.

Authors:  Richard Furie; Margaret Mitrane; Enxu Zhao; Maya Das; Daner Li; Patrice M Becker
Journal:  Lupus Sci Med       Date:  2016-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.